deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT04669288

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)

Sponsor: Boston Children's Hospital

Conditions Asthma Wheezing
Interventions Azithromycin Placebo
Updated 13 times since 2021 Last updated: Feb 27, 2025 Started: Sep 22, 2021 Primary completion: Dec 10, 2024 Completion: Jan 8, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The AZ-SWED trial was stopped by the National Heart, Lung, and Blood Institute (NHLBI) due to futility

Other terminated trials from Boston Children's Hospital

See all terminations from Boston Children's Hospital

Other Asthma trials with similar outcome

Browse all Asthma trials

A PHASE3 clinical study on Asthma and Wheezing, this trial is terminated or withdrawn. The trial is conducted by Boston Children's Hospital and has accumulated 13 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshot~Nov 2021 – ~Mar 2022 · 4 months · monthly snapshot~Mar 2022 – ~Jun 2022 · 3 months · monthly snapshot~Jun 2022 – ~Nov 2022 · 5 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Dec 2023 · 12 months · monthly snapshot~Dec 2023 – ~Feb 2024 · 2 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Mar 2025 · 59 days · monthly snapshot~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – present · 15 months · monthly snapshot

Change History

13 versions recorded

  1. Apr 2025 — Present [monthly]

    Terminated PHASE3

  2. Mar 2025 — Apr 2025 [monthly]

    Terminated PHASE3

    Status: Active Not Recruiting → Terminated

  3. Jan 2025 — Mar 2025 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  4. Sep 2024 — Jan 2025 [monthly]

    Recruiting PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

▶ Show 8 earlier versions

  1. Feb 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  2. Dec 2023 — Feb 2024 [monthly]

    Recruiting PHASE3

  3. Dec 2022 — Dec 2023 [monthly]

    Recruiting PHASE3

    Status: Suspended → Recruiting

  4. Nov 2022 — Dec 2022 [monthly]

    Suspended PHASE3

    Status: Recruiting → Suspended

  5. Jun 2022 — Nov 2022 [monthly]

    Recruiting PHASE3

    Status: Suspended → Recruiting

  6. Mar 2022 — Jun 2022 [monthly]

    Suspended PHASE3

    Status: Recruiting → Suspended

  7. Nov 2021 — Mar 2022 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  8. Jan 2021 — Nov 2021 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston Children's Hospital
  • Children's Hospital Medical Center, Cincinnati
  • Children's Hospital and Health System Foundation, Wisconsin
  • Children's Hospital of Philadelphia
  • Emory University
  • Morgan Stanley Children's Hospital
  • University of Arizona
  • University of Pittsburgh
  • University of Utah
Data source: University of Arizona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations